Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

103.07
-0.8900-0.86%
Pre-market: 103.240.1705+0.17%07:29 EDT
Volume:494.69K
Turnover:50.84M
Market Cap:4.68B
PE:50.28
High:103.95
Open:103.06
Low:101.39
Close:103.96
52wk High:109.57
52wk Low:47.32
Shares:45.45M
Float Shares:44.60M
Volume Ratio:0.81
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.05
EPS(LYR):2.05
ROE:11.20%
ROA:6.60%
PB:5.60
PE(LYR):50.28

Loading ...

Aug 18, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 06, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 29, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Major Issues Report

Form 8-K - Current report
May 20, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 01, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 03, 2026

Major Issues Report

Form 8-K - Current report
Feb 13, 2026

Major Issues Report

Form 8-K - Current report
Feb 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 05, 2026

Major Issues Report

Form 8-K - Current report
Jan 09, 2026

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]